findmyKOL

Martin Bergman, MD

Basic profile

Gynecologic Oncology Group

ORCIDNPI
RegionRidley Park, PA · NortheastSpecialtyRheumatologyFocusRheumatology/Immunology
Last active 2024findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2021Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Martin Bergman is a Rheumatology/Immunology physician affiliated with Gynecologic Oncology Group. OpenAlex indexes 163 publications with 5,941 citations (h-index 33).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
163publications

Distinct works indexed by OpenAlex, matched via ORCID.

5,941citations

Total citations across indexed works.

33h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
23companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

23 W Chester Pike Ste 201
Ridley Park, PA 190781629

Telephone

610-521-1701

Registry record last updated 27 Jun 2019.

View the NPPES registry record

Industry payments

23 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    38.4%
    Folate Analog Metabolic Inhibitor14.5%
    Methotrexate100%
    Part D38 patients
    TNF inhibitor10.2%
    Enbrel Sureclick64%Humira(Cf) Pen23%Humira(Cf)13%
    Part D<11 patients

    + 4 more classes in this area

  • Nervous system

    16.3%
    Opioid Agonist6.2%
    Tramadol Hcl48%Oxycodone Hcl30%Oxycontin21%
    Part D<11 patients
    Nonsteroidal Anti-inflammatory Drug5.2%
    Meloxicam66%Ibuprofen34%
    Part D<11 patients

    + 2 more classes in this area

  • Antiparasitic

    16.1%
    Antimalarial16.1%
    Hydroxychloroquine Sulfate100%
    Part D41 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”